Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma?

Systemic therapy is a key management component of pancreatic ductal adenocarcinoma(PDAC). Racial disparities exist in PDAC, often linked to socioeconomic variables. We investigated the impact of race in PDAC patients who had undergone systemic therapy and surgical resection. A retrospective analysis...

Full description

Saved in:

Bibliographic Details
Published in:	The American journal of surgery Vol. 224; no. 3; pp. 955 - 958
Main Authors:	Irfan, Ahmer, Fang, Hua A., Awad, Seifeldin, Alkashah, Ahmad, Vickers, Selwyn M., Gbolahan, Olumide, Williams, Grant R., Nien-Tsu Wang, Thomas, Dudeja, Vikas, Rose, J. Bart, Reddy, Sushanth
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-09-2022 Elsevier Limited
Subjects:	Adenocarcinoma Adjuvant therapy Cancer therapies Carcinoma, Pancreatic Ductal Chemotherapy Disparities in care Humans Inequality Lymphatic system Mortality Pancreas Pancreatic adenocarcinoma Pancreatic cancer Pancreatic Neoplasms Patients Race Race factors Racial differences Retrospective Studies Social factors Statistical analysis Survival Survival analysis Therapy Tumors Variance analysis United States > US Pancreatic adenocarcinoma PDAC Adjuvant therapy UAB Disparities in care
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!